PPMD is proud to join dozens of other rare disease nonprofit organizations in asking Congressional leaders to reauthorize the FDA user fee agreements.
The current FDA user fee agreements are the culmination of months of negotiation between FDA and the medical product industry, with significant input from the patient advocacy community.
Read the letter PPMD has signed on to.
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this